Compare Aurora Cannabis Inc (ACB) vs Eos Energy Enterprises Inc (EOSE) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

EOSE trades at $5.06, down 3.25% today, amid a bearish technical signal despite a recent Q1 2026 earnings beat. The company shows rapid revenue growth but deep losses, with a net income margin of -296.13% in 2026. Recent news highlights progress in its Frontier Power USA venture and new supply agreements, yet cash flow remains negative from operations, relying on financing.

The outlook is mixed: analyst consensus is a Buy with a $8.33 price target, signaling potential upside, but high execution risk persists given substantial losses and a debt-to-asset ratio of 91.87%. Investors face volatility from operational cash burn against growth initiatives in the competitive energy storage market.